Why Ukraine? All the advantages of the Ukrainian market in comparison with the other emerging countries of Europe are summarized here in 7 key items:
1. Central location
Ukraine is situated in the center of Eastern Europe, on the crossroads of important transportation routes from Europe to Asia and from the Scandinavian countries to the Mediterranean region.
2. Huge naïve patient pool
Ukraine is a big country with a centralized state healthcare system and, at the same time, has one of the lowest rate of international clinical trials/population in Europe.
3. Research-friendly country regulations
The Regulatory Authorities in Ukraine during the last years have made some key regulating steps improving and simplifying the country clinical research environment: quicker start-up, shorter list of applying documents, less IMP import costs.
4. Highly educated monitors
Due to the unique social background, the highly educated employees with medical and pharmacological backgrounds represent around 90% of the clinical research staff. This percentage will not go down in the near future in Ukraine.
5. Highly motivated investigators
Investigators are highly interested in participation in more international clinical trials and do their best demonstrating the excellent study results and their real willingness to build perspective long-term partnerships with the sponsors and CROs.
6. Low project costs per subject
On average, the investigators’/hospitals’/institutions’ study fees and the monitoring cost per study subject in Ukraine are 25% lower than those in the EU. Moreover, quick and efficient study enrollment in Ukraine reduces the time required for recruitment, which saves money dramatically.
7. High quality performance
Most customers conducting clinical trials in Ukraine are impressed by quick recruitment and high quality performance in Ukraine. It is a fact!